Preclinical characterization of GSK532, a novel STING agonist with potent anti-tumor activity

被引：10
|
作者：
Yang, Jingsong [1 ]
Adam, Michael [1 ]
Clemens, Jim [1 ]
Creech, Katrina [1 ]
Schneck, Jess [1 ]
Pasikanti, Kishore [1 ]
Jean-Luc Tran [1 ]
Joglekar, Devika [1 ]
Hopson, Chris [1 ]
Pesiridis, Scott [1 ]
Ramanjulu, Joshi [1 ]
Lian, Yiqian [1 ]
Adams, Jerry L. [1 ]
Smothers, James [1 ]
Hoos, Axel [1 ]
机构：
[1] GlaxoSmithKline, Collegeville, PA USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-5554
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5554
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Preclinical characterization of ALG-031048, a novel STING agonist with potent anti-tumor activity in mice
    Jekle, Andreas
    Thatikonda, Santosh
    Stevens, Sarah
    Williams, Caroline
    Kinkade, April
    Ren, Suping
    Jaisinghani, Ruchika
    Zhang, Qingling
    Misner, Dinah
    Stoycheva, Antitsa
    Deval, Jerome
    Mukherjee, Sucheta
    Gonzalvez, Francois
    Chanda, Sushmita
    Smith, David B.
    Symons, Julian A.
    Blatt, Lawrence M.
    Beigelman, Leonid
    CANCER RESEARCH, 2020, 80 (16)
  • [2] Discovery of novel STING agonists with robust anti-tumor activity
    Li, Anrong
    Song, Yuntao
    Dong, Chen
    Chen, Xiaoqi
    Yang, Junbao
    CANCER RESEARCH, 2020, 80 (16)
  • [3] Characterization of a novel class of RAS inhibitory compounds with potent anti-tumor activity
    Ward, Antonio
    Chen, Xi
    Valiyaveettil, Jacob
    Zhu, Bing
    Ramirez-Alcantara, Veronica
    Lee, Kevin J.
    Lindsey, Ashley
    Berry, Kristy
    Mattox, Tyler E.
    McConnell, Kate
    Boyd, Michael R.
    Piazza, Gary A.
    Keeton, Adam B.
    CANCER RESEARCH, 2017, 77
  • [4] Preclinical development of a novel oral multitargeted kinase inhibitor with potent in vivo anti-tumor activity
    Beaulieu, Normand
    Dupont, Isabelle
    Hannah Nguyen
    Carole, Beaulieu
    Ste-Croix, Helene
    Robert, Marie-France
    Lefebvre, Sylvain
    Lu, Ai Hua
    Dubay, Maria
    Rahil, Gabi
    Wang, James
    Mannion, Michael
    Raeppel, Stephane
    Saavedra, Oscar
    Claridge, Stephen
    Isakovic, Lubo
    Zhan, Lijie
    Gaudette, Frederic
    Zhou, Nancy
    Nantel, Miguel
    Raeppel, Franck
    Vaisburg, Arkadii
    Besterman, Jeffrey
    Maroun, Christiane
    CANCER RESEARCH, 2009, 69
  • [5] Preclinical characterization of a novel non-cyclic dinucleotide small molecule STING agonist with potent antitumor activity in mice
    Wang, Zezhou
    Dove, Peter
    Rosa, David
    Bossen, Bolette
    Helke, Simone
    Charbonneau, Marilyse
    Brinen, Laura
    Dodge, Karen
    Lin, Gloria H.
    Galligan, Carole
    Viller, Natasja N.
    Wong, Mark
    Lee, Vivian
    Catalano, Tina
    Uger, Robert A.
    Slassi, Malik
    Winston, Jeff
    CANCER RESEARCH, 2019, 79 (13)
  • [6] Characterization of a novel anti-CD20 Stradobody™ with potent in vitro anti-tumor activity
    Zhang, Xiaoyu
    Burch, Erin
    Chen, Shaodong
    Sallin, Michelle
    Olsen, Henrik
    Block, David
    Strome, Scott
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [7] Tumor targeting of a STING agonist with an antibody-drug conjugate elicits potent anti-tumor immune responses
    Cetinbas, Naniye Malli
    Catcott, Kalli
    Avocetien, Kenneth
    Bentley, Keith
    Carter, Tyler
    Chin, Chen-Ni
    Clardy, Susan
    Eitas, Timothy
    Jones, Brian
    Kelleher, Eoin
    Mosher, Rebecca
    Nazzaro, Mark
    Nehilla, Barrett
    Protopopova, Marina
    Shaw, Pamela
    Slocum, Kelly
    Qin, LiuLiang
    Thomas, Josh
    Yang, Liping
    Toader, Dorin
    Damelin, Marc
    Duvall, Jeremy
    Bukhalid, Raghida
    Lowinger, Timothy
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [8] A novel docetaxel derivative exhibiting potent anti-tumor activity and high safety in preclinical animal models
    Wang, Yao
    Wang, Penghui
    Zhou, Linzhu
    Su, Yue
    Zhou, Yongfeng
    Zhu, Xinyuan
    Huang, Wei
    Yan, Deyue
    BIOMATERIALS SCIENCE, 2022, 10 (17) : 4876 - 4888
  • [9] Vorolanib, a novel tyrosine receptor kinase receptor inhibitor with potent preclinical anti-angiogenic and anti-tumor activity
    Liang, Chris
    Yuan, Xiaobin
    Shen, Zhilin
    Wang, Yang
    Ding, Lieming
    MOLECULAR THERAPY-ONCOLYTICS, 2022, 24 : 577 - 584
  • [10] Preclinical characterization of a novel STING agonist, MK-1454
    Cemerski, Saso
    Altman, Michael
    Bandi, Madhavi
    Chang, Wonsuk
    Chen, Yiping
    Cui, Long
    Cumming, Jared
    Dorosh, Lauren
    Flateland, Lauren
    Ma, Yanhong
    Javaid, Sarah
    Ho, Thu
    Kopinja, Johnny
    Laskey, Jason
    Minnihan, Ellen
    Price, Laura
    Mogg, Robin
    O'Donnell, Gregory
    Pan, Bo-Sheng
    Perera, Samanthi
    Piesvaux, Jennifer
    Presland, Jeremy
    Rakhilina, Larissa
    Schroeder, Gottfried
    Slavonic, Michael
    Smock, Steven
    Trotter, Benjamin Wesley
    Wyss, Daniel
    Zhao, Qing
    Zhao, Shuxia
    Sadekova, Svetlana
    Yu, Ying
    Khilnani, Anuradha
    Tse, Archie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
12345